Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users

Journal of Infectious Diseases

Volumn 195, Issue 7, 2007, Pages 1052-1061

  Neaigus, Alan ^a,b,e   Gyarmathy, V Anna ^a,d   Zhao, Mingfang ^a   Miller, Maureen ^b   Friedman, Samuel R ^a,d   Des Jarlais, Don C ^a,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Beth Israel Medical Center ^*  (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; HEPATITIS B CORE ANTIBODY;

ADULT; ARTICLE; DRUG USE; FEMALE; FOLLOW UP; HAZARD RATIO; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEROCONVERSION; SEXUAL BEHAVIOR; UNITED STATES;

ADULT; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEROIN DEPENDENCE; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; NEW YORK CITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES;

EID: 33947386269     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/512081     Document Type: Article

References (50)

1. United Nations Office on Drugs and Crime. World drug report 2005. Volume 1: Analysis. Vienna, Austria: United Nations Information Service, 2005.
2. Substance Abuse and Mental Health Services Administration. Results from the 2004 National Survey on Drug Use and Health: National Findings. rep SMA 05-4062. Rockville, MD: US Department of Health and Human Services, 2005.
3. Strang J, Griffiths P, Powis B, Gossop M. First use of heroin: changes in the route of administration over time. BMJ 1992; 304:1222-3.
4. Grund JP, Blanken P. From chasing the dragon to chinezen: the diffusion of heroin smoking in the Netherlands. Rotterdam, the Netherlands: Erazmus University, Institut Voor Verslavinason der Zoek, 1993.
5. Schottenfeld RS, O'Malley S, Abdul-Salaam K, O'Connor PG. Decline in intravenous drug use among treatment-seeking opiate users. J Subst Abuse Treat 1993; 10:5-10.
6. Bowersox JA. Heroin update: smoking, injecting cause similar effects; usage patterns may be shifting. National Institute on Drug Abuse Notes 1995. Available at: http://www.nida.nih.gov/NIDA_Notes/NNVol10N4/ HeroinUpdate.html. Accessed 21 February 2007.
7. de la Fuente L, Saavedra P, Barrio G, Royuela L, Vincente J. Spanish group for the study of the purity of seized drugs: temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Drug Alcohol Depend 1996; 40:185-94.
8. Marel R, Galea J, Smith RB. Drug use trends in New York City. New York, NY: New York State Office of Alcoholism and Substance Abuse Services, 2003.
9. Thomas DL, Cannon RO, Shapiro CN, Hook EW III, Alter MJ, Quinn TC. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 1994; 169:990-5.
10. Ndimbie OK, Kingsley LA, Nedjar S, Rinaldo CR. Hepatitis C virus infection in a male homosexual cohort: risk factor analysis. Genitourin Med 1996; 72:213-6.
11. Rooney G, Gilson RJ. Sexual transmission of hepatitis C virus infection. Sex Transm Infect 1998; 74:399-404.
12. Wejstal R. Sexual transmission of hepatitis C virus. J Hepatol 1999; 31(Suppl 1):92-5.
13. Feldman JG, Minkoff H, Landesman S, Dehovitz J. Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women. Sex Transm Dis 2000; 27:338-42.
14. Marx MA, Murugavel KG, Tarwater PM, et al. Association of hepatitis C virus infection with sexual exposure in southern India. Clin Infect Dis 2003; 37:514-20.
15. Rauch A, Rickenbach M, Weber R, et al. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis 2005; 41:395-402.
16. Chiasson MA, Stoneburner RL, Hildebrandt DS, Ewing WE, Telzak EE, Jaffe HW. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 1991; 5:1121-6.
17. Edlin BR, Irwin KL, Faruque S, et al. Intersecting epidemics - crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N Engl J Med 1994; 331:1422-7.
18. Neaigus A, Miller M, Friedman SR, Des Jarlais DC. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. J Infect Dis 2001; 184:359-63.
19. Miller M, Neaigus A. Sex partner support, drug use and sex risk among HIV-negative non-injecting heroin users. AIDS Care 2002; 14:801-13.
20. Sanchez J, Comerford M, Chitwood DD, Fernandez MI, McCoy CB. High risk sexual behaviours among heroin sniffers who have no history of injection drug use: implications for HIV risk reduction. AIDS Care 2002; 14:391-8.
21. Gyarmathy VA, Neaigus A, Miller M, Friedman SR, Des Jarlais DC. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr 2002; 30:448-56.
22. Tortu S, McMahon JM, Pouget ER, Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst Use Misuse 2004; 39:211-24.
23. Howe CJ, Fuller CM, Ompad DC, et al. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend 2005; 79:389-95.
24. Neaigus A, Friedman SR, Curtis R, et al. The relevance of drug injectors' social networks and risk networks for understanding and preventing HIV infection. Soc Sci Med 1994; 38:67-78.
25. Neaigus A, Friedman SR, Jose B, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:499-509.
26. Watters J, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Probl 1989; 6:416-30.
27. Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl 1997; 44:174-99.
28. Sifaneck SJ, Neaigus A. The ethnographic accessing, sampling and screening of hidden populations: heroin sniffers in New York City. Addiction Res Theory 2001; 9:519-43.
29. van Ameijden EJC, van den Hoek JAR, Hartgers C, Coutinho RA. Risk factors for the transition from non-injecting to injecting drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol 1994; 139:1153-63.
30. Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS 2000; 14:605-11.
31. Neaigus A, Miller M, Friedman SR, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 2001; 96:847-60.
32. Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among non-injecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr 2006; 41:493-503.
33. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer-Verlag, 2000.
34. Des Jarlais DC, Diaz T, Perlis T, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 2003; 157:467-71.
35. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1997; 46(RR-18):1-42.
36. Ippolito G, Puro V, Heptonstall J, Jagger J, De Carli G, Petrosillo N. Occupational human immunodeficiency virus infection in health care workers: worldwide cases through September 1997. Clin Infect Dis 1999; 28:365-83.
37. Wohl AR, Johnson DF, Lu S, et al. HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual. J Acquir Immune Defic Syndr 2002; 31:354-60.
38. Miller M, Serner M, Wagner M. Sexual diversity among black men who have sex with men in an inner-city community. J Urban Health 2005; 82(Suppl 1):i26-i34.
39. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002; 51(RR-6):1-78.
40. Remis RS, Dufour A, Alary M, et al. Association of hepatitis B virus infection with other sexually transmitted infections in homosexual men. Omega Study Group. Am J Public Health 2000; 90:1570-4.
41. Alter MJ. Hepatitis C virus infection in the United States. J Hepatol 1999; 31(Suppl 1):88-91.
42. National Institutes of Health. Consensus Development Conference statement: management of hepatitis C, 2002. Washington, DC: National Institutes of Health, 2002.
43. Ghosn J, Pierre-Francois S, Thibault V, et al. Acute hepatitis C in HIV-infected men who have sex with men. HIV Med 2004; 5:303-6.
44. Gambotti L, Acute Hepatitis C Collaborating Group. Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. Euro Surveill 2005; 10(5):115-7.
45. Gotz H, van Doornum G, Niesters H, den Hollander J, Thio H, de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men - results from contact tracing and public health implications. AIDS 2005; 19:969-74.
46. Roy E, Haley N, Leclerc P, Boivin JF, Cedras L, Vincelette J. Risk factors for hepatitis C virus infection among street youths. Can Med Assoc J 2001; 165:557-60.
47. D'Souza G, Arafat R, Hwang L, Cunningham C, Shah S, Reynolds K. Cross-sectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services' sexually transmitted disease clinics. J Viral Hepat 2003; 10:I34-40.
48. Kummer LJ. Drug users transform their hard lessons into tools to teach doctors. New York Times 2006, April 2.
49. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5:215-29.
50. Ziek K, Beardsley M, Deren S, Tortu S. Predictors of follow-up in a sample of urban crack smokers. Evaluation Program Plann 1996; 19:219-24.